For the EASL Panel of Experts on hepatocellular carcinoma

Jordi Bruix; Morris Sherman; Josep M. Llovet; Michel Beaugrand; R Lenicioni; AK Burroughs; Emil Christensen; Lance C. Pagliaro; Massimo Colombo; J Rodés

Article2001

Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference

Jordi Bruix, Morris Sherman, Josep M. Llovet, Michel Beaugrand, Riccardo Lencioni, Andrew K. Burroughs, Erik Christensen, Luigi Pagliaro, Massimo Colombo, Juan Rodés

Journal of Hepatology

Article2012

EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma European Association for the Study of the Liver ⇑ , European Organisation for Research and Treatment of Cancer

Josep M. Llovet, Michel Ducreux, Riccardo Lencioni, Adrian M. Di Bisceglie, Jean‐François Dufour, Tim F. Greten, Éric Raymond, Tania Roskams, Vincenzo Mazzaferro, Jordi Bruix, Massimo Colombo, Andrew X. Zhu

Article2004

Focus on hepatocellular carcinoma

Jordi Bruix, Loreto Boix, María Sala, Josep M. Llovet

Cancer Cell

Article2021

Immunotherapies for hepatocellular carcinoma

Josep M. Llovet, Florian Castet, Mathias Heikenwälder, Mala K. Maini, Vincenzo Mazzaferro, David J. Pinato, Eli Pikarsky, Andrew X. Zhu, Richard S. Finn

Nature Reviews Clinical Oncology

Article2007

Emerging agents for the medical therapy of hepatocellular carcinoma.

Josep M. Llovet

PubMed

For the EASL Panel of Experts on hepatocellular carcinoma

Abstract

Discussion(0)

Related publications

Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference

EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma European Association for the Study of the Liver ⇑ , European Organisation for Research and Treatment of Cancer

Focus on hepatocellular carcinoma

Immunotherapies for hepatocellular carcinoma

Emerging agents for the medical therapy of hepatocellular carcinoma.